Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Personal Injury Law

: Philadelphia Personal Injury Lawyer

New Warnings For Tarceva

By Jamie Sheller

ADVERTISEMENTS

According to the FDA, the cancer drug Tarceva will soon get new warnings added to its label. Tarceva is made by Genentech Inc. and OSI Pharmaceuticals Inc. Physicians were notified of these label changes in April, but the "dear doctor" letter sent by the companies was only recently made public by the FDA. Tarceva monotherapy is used to treat locally advanced or metastic non-small cell lung cancer, after other chemotherapy treatments have failed. When Tarceva is combined with gemcitabine hydrochloride, it is a first-line treatment for locally advanced, unresectable or metastatic pancreatic cancer. Reports of gastrointestinal problems and skin reactions will be included on the new labels for Tarceva. Some of the serious problems linked to Tarceva include gastrointestinal perforation, exfoliative skin conditions, and corneal ulcers. There are also suggestions of Stevens-Johnson syndrome and toxic epidermal necrolysis. Some of the reported cases involved patient deaths.

Originally posted at InjuryBoard by Jamie Sheller

Full post as published by Philadelphia Personal Injury Lawyer on May 27, 2009 (boomark / email).

Lawsuits and Settlements

Tarceva
Safety Data Show Association with Liver Failure and Death

Acetaminophen
FDA Wants New Safety Warnings

CellCept
Roche Issues Changes to Warnings and Adverse Events

Darvon
Other Propoxyphene-Containing Meds to Require Stronger Warnings

Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin. The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

Related Searches